Chronic myeloid leukemia in adolescents and young adults: Patient characteristics, outcomes and review of the literature

Naveen Pemmaraju, Jorge Cortes

Research output: Contribution to journalReview article

Abstract

Over the past two decades, many improvements have been made in the management of patients with leukemia. Research in this field most often focuses on the youngest and oldest patient age groups. However, the population of patients in between those age groups has received relatively little attention with few studies specifically focusing on them. This important 'age gap' has demonstrated a unique, difficult-to-treat group of patients known as adolescents and young adults, or AYAs. Variably defined in the literature as patients from late teenage years to the age of up to 40 years, the AYA group of patients represents a vulnerable subset of patients now identified to require its own focus, development of therapeutic strategies and parallel emphasis on special support systems involving multidisciplinary psychosocial care. Despite the great advancements that have been realized for patients with chronic myeloid leukemia (CML), the AYA group has seldom been the focus of specific reports and studies, and the outcome appears to lag behind the general population. This review focuses on this subset of AYA patients with CML and summarizes the available data and recent developments, challenges and treatment options for this group of patients.

Original languageEnglish (US)
Pages (from-to)298-306
Number of pages9
JournalActa Haematologica
Volume132
Issue number3-4
DOIs
StatePublished - Apr 12 2014
Externally publishedYes

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Young Adult
Age Groups
Population
Leukemia
Outcome Assessment (Health Care)
Therapeutics

Keywords

  • Adolescent and young adult
  • Chronic myeloid leukemia

ASJC Scopus subject areas

  • Hematology

Cite this

Chronic myeloid leukemia in adolescents and young adults : Patient characteristics, outcomes and review of the literature. / Pemmaraju, Naveen; Cortes, Jorge.

In: Acta Haematologica, Vol. 132, No. 3-4, 12.04.2014, p. 298-306.

Research output: Contribution to journalReview article

@article{eb41e0edd9554f82baa747fffd2dabfd,
title = "Chronic myeloid leukemia in adolescents and young adults: Patient characteristics, outcomes and review of the literature",
abstract = "Over the past two decades, many improvements have been made in the management of patients with leukemia. Research in this field most often focuses on the youngest and oldest patient age groups. However, the population of patients in between those age groups has received relatively little attention with few studies specifically focusing on them. This important 'age gap' has demonstrated a unique, difficult-to-treat group of patients known as adolescents and young adults, or AYAs. Variably defined in the literature as patients from late teenage years to the age of up to 40 years, the AYA group of patients represents a vulnerable subset of patients now identified to require its own focus, development of therapeutic strategies and parallel emphasis on special support systems involving multidisciplinary psychosocial care. Despite the great advancements that have been realized for patients with chronic myeloid leukemia (CML), the AYA group has seldom been the focus of specific reports and studies, and the outcome appears to lag behind the general population. This review focuses on this subset of AYA patients with CML and summarizes the available data and recent developments, challenges and treatment options for this group of patients.",
keywords = "Adolescent and young adult, Chronic myeloid leukemia",
author = "Naveen Pemmaraju and Jorge Cortes",
year = "2014",
month = "4",
day = "12",
doi = "10.1159/000363434",
language = "English (US)",
volume = "132",
pages = "298--306",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Chronic myeloid leukemia in adolescents and young adults

T2 - Patient characteristics, outcomes and review of the literature

AU - Pemmaraju, Naveen

AU - Cortes, Jorge

PY - 2014/4/12

Y1 - 2014/4/12

N2 - Over the past two decades, many improvements have been made in the management of patients with leukemia. Research in this field most often focuses on the youngest and oldest patient age groups. However, the population of patients in between those age groups has received relatively little attention with few studies specifically focusing on them. This important 'age gap' has demonstrated a unique, difficult-to-treat group of patients known as adolescents and young adults, or AYAs. Variably defined in the literature as patients from late teenage years to the age of up to 40 years, the AYA group of patients represents a vulnerable subset of patients now identified to require its own focus, development of therapeutic strategies and parallel emphasis on special support systems involving multidisciplinary psychosocial care. Despite the great advancements that have been realized for patients with chronic myeloid leukemia (CML), the AYA group has seldom been the focus of specific reports and studies, and the outcome appears to lag behind the general population. This review focuses on this subset of AYA patients with CML and summarizes the available data and recent developments, challenges and treatment options for this group of patients.

AB - Over the past two decades, many improvements have been made in the management of patients with leukemia. Research in this field most often focuses on the youngest and oldest patient age groups. However, the population of patients in between those age groups has received relatively little attention with few studies specifically focusing on them. This important 'age gap' has demonstrated a unique, difficult-to-treat group of patients known as adolescents and young adults, or AYAs. Variably defined in the literature as patients from late teenage years to the age of up to 40 years, the AYA group of patients represents a vulnerable subset of patients now identified to require its own focus, development of therapeutic strategies and parallel emphasis on special support systems involving multidisciplinary psychosocial care. Despite the great advancements that have been realized for patients with chronic myeloid leukemia (CML), the AYA group has seldom been the focus of specific reports and studies, and the outcome appears to lag behind the general population. This review focuses on this subset of AYA patients with CML and summarizes the available data and recent developments, challenges and treatment options for this group of patients.

KW - Adolescent and young adult

KW - Chronic myeloid leukemia

UR - http://www.scopus.com/inward/record.url?scp=84908610463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908610463&partnerID=8YFLogxK

U2 - 10.1159/000363434

DO - 10.1159/000363434

M3 - Review article

C2 - 25228555

AN - SCOPUS:84908610463

VL - 132

SP - 298

EP - 306

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 3-4

ER -